Goat Anti-Mouse Anti-Rabbit IgG/IgM H&L (HRP polymer) (ab2891)
Key features and details
- Goat Anti-Mouse Anti-Rabbit IgG/IgM H&L (HRP polymer)
- Conjugation: HRP polymer
- Host species: Goat
- Isotype: IgG
- Suitable for: IHC-P, IHC-Fr
製品の概要
-
製品名
Goat Anti-Mouse Anti-Rabbit IgG/IgM H&L (HRP polymer)
IgG + IgM 二次抗体 製品一覧 -
製品の詳細
Goat Anti-Mouse Anti-Rabbit IgG/IgM H&L (HRP polymer) -
由来種
Goat -
ターゲット生物種
Mouse -
特異性
This antibody reacts with heavy and light chains on mouse and rabbit IgG. It reacts with all mouse and rabbit IgG subclasses and with mouse and rabbit IgM. -
アプリケーション
適用あり: IHC-P, IHC-Frmore details -
標識
HRP polymer
製品の特性
-
製品の状態
Liquid -
保存方法
Shipped at 4°C. Store at +4°C. -
Concentration information loading...
-
特記事項(標識)
HRP conjugated to a polymer backbone, which is collectively conjugated to the antibody. The effect is multiple HRP molecules linked to one single antibody. -
ポリ/モノ
ポリクローナル -
アイソタイプ
IgG -
特記事項
This new and innovative HRP-polymerization technology provides a significant increase in staining sensitivity when compared to other conventional HRP-conjugated secondary antibodies. Avidin-biotin blocking procedures are not necessary when using this product. The overall staining procedure uses one less reagent (streptavidin peroxidase) and rinsing step, eliminates avidin-biotin blocking procedures and may reduce overall staining time.
-
研究分野
関連製品
-
Substrate reagent
- TMB ELISA Substrate (Highest Sensitivity) (ab171522)
- TMB ELISA Substrate (High Sensitivity) (ab171523)
- TMB ELISA Substrate (Fast Kinetic Rate) (ab171524)
- TMB ELISA Substrate (Slow Kinetic Rate) (ab171525)
- TMB ELISA Substrate (Slower Kinetic Rate) (ab171526)
- TMB ELISA Substrate (Slowest Kinetic Rate) (ab171527)
アプリケーション
Our Abpromise guarantee covers the use of ab2891 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
アプリケーション | Abreviews | 特記事項 |
---|---|---|
IHC-P | Use at an assay dependent dilution. | |
IHC-Fr | Use at an assay dependent dilution. This product is provided in a pre-diluted, ready-to-use format. Apply for 20 - 30 minutes. |
プロトコール
To our knowledge, customised protocols are not required for this product. Please try the standard protocols listed below and let us know how you get on.
データシートおよび資料
参考文献 (11)
ab2891 は 11 報の論文で使用されています。
- Feng C et al. Tumor-Suppressive MicroRNA-216b Binds to TPX2, Activating the p53 Signaling in Human Cutaneous Squamous Cell Carcinoma. Mol Ther Nucleic Acids 20:186-195 (2020). PubMed: 32169806
- Qi Y et al. Expression of BDNF, TrkB, VEGF and CD105 is associated with pelvic lymph node metastasis and prognosis in IB2-stage squamous cell carcinoma. Exp Ther Med 18:4221-4230 (2019). PubMed: 31777532
- Mesci P et al. Blocking Zika virus vertical transmission. Sci Rep 8:1218 (2018). PubMed: 29352135
- Shiryaev SA et al. Repurposing of the anti-malaria drug chloroquine for Zika Virus treatment and prophylaxis. Sci Rep 7:15771 (2017). PubMed: 29150641
- Conway MJ et al. Mosquito saliva serine protease enhances dissemination of dengue virus into the mammalian host. J Virol 88:164-75 (2014). PubMed: 24131723